Existing biomarkers for the diagnosis of Alzheimer’s disease include (1) Aβ42 (the 42 amino acid form of amyloid β) in CSF and (2) total and phosphorylated tau protein in CSF [20]. This evidence concerns the gene MAPT and Alzheimer disease.